ezogabine has been researched along with Migraine Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ankarali, S; Citak, A; Dagistan, Y; Kilinc, E; Torun, IE; Yoldas, H | 1 |
| Dworetzky, SI; Wua, YJ | 1 |
1 review(s) available for ezogabine and Migraine Disorders
| Article | Year |
|---|---|
Recent developments on KCNQ potassium channel openers.
Topics: Acrylamides; Aminopyridines; Benzamides; Carbamates; Epilepsy; Humans; Indoles; Ion Channel Gating; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Migraine Disorders; Oxindoles; Pain; Phenylenediamines; Potassium Channels, Voltage-Gated | 2005 |
1 other study(ies) available for ezogabine and Migraine Disorders
| Article | Year |
|---|---|
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system.
Topics: Animals; Calcitonin Gene-Related Peptide; Male; Migraine Disorders; Neurogenic Inflammation; Rats; Rats, Wistar; Transient Receptor Potential Channels; Trigeminal Ganglion; TRPV Cation Channels | 2022 |